Stockreport

Bristol Myers Sees Over $85 Billion of Demand for M&A Bond Sale [BNN Bloomberg (Canada)]

RayzeBio, Inc.  (RYZB) 
PDF Therapeutics Inc. and RayzeBio Inc., according to people with knowledge of the matter. The company is said to be targeting $13 billion, according to a person familiar [Read more]